Copyright
©The Author(s) 2019.
World J Clin Cases. Mar 6, 2019; 7(5): 562-571
Published online Mar 6, 2019. doi: 10.12998/wjcc.v7.i5.562
Published online Mar 6, 2019. doi: 10.12998/wjcc.v7.i5.562
Angiography | |
Defect size on LV side, mm, mean ± SD | 6.7 ± 1.5 |
Defect size on RV side, mm, mean ± SD | 3.5 ± 0.6 |
Routine right and left heart catheterization | |
sPAP, mmHg, mean ± SD | 31.4 ± 4.4 |
mPAP, mmHg, mean ± SD | 19.6 ± 3.6 |
Qp/Qs, mean ± SD | 2.3 ± 0.4 |
Occluder size, n (%) | |
6 mm | 3 (15.0) |
7 mm | 3 (15.0) |
8 mm | 5 (25.0) |
9 mm | 5 (25.0) |
10 mm | 3 (15.0) |
12 mm | 1 (5.0) |
Average operative time, min, mean ± SD | 49.3 ± 6.0 |
Average fluoroscopy time, min, mean ± SD | 24.3 ± 2.8 |
Post-procedural complications, n (%) | |
CRBBB (transient) | 1 (5.0) |
Increased TR, n (%) | 1 (5.0) |
Sheath, Fr, median (IQR) | 8.0 (2.0) |
- Citation: He L, Du YJ, Cheng GS, Zhang YS. Safety of an improved patent ductus arteriosus occluder for transcatheter closure of perimembranous ventricular septal defects with abnormally attached tricuspid chordae tendineae. World J Clin Cases 2019; 7(5): 562-571
- URL: https://www.wjgnet.com/2307-8960/full/v7/i5/562.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i5.562